Sun Pharma Advanced Research Company Other Announcement
Sun Pharma Advanced Research filed its monitoring agency report on warrant issue proceeds for the quarter ended September 30, 2026. The agency found no deviation from objects.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Sun Pharma Advanced Research filed its monitoring agency report on warrant issue proceeds for the quarter ended September 30, 2026. The agency found no deviation from objects.
Sun Pharma Advanced Research Company Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Sun Pharma Advanced Research Company Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026.
Sun Pharma Advanced Research Company Limited submitted the Monitoring Agency Report for the quarter ended June 30, 2026. The report confirms zero deviation in utilizing proceeds from its Rs. 599.98 Crore warrant issue.
Sun Pharma Advanced Research Company Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026. The filing details equity holdings across promoter and public categories.